🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 648.57 -1.7% NASDAQ 100: 582.06 -1.9% Dow Jones: 455.89 -1.1%

Aldeyra Therapeutics, Inc.

ALDX Healthcare
$1.81 $-0.02 (-1.09%)
Market Cap: $108.93 M
Gurus Holding
3
Popularity Rank
#2701
% of Shares Held
2.78%
Net Activity (Q4 2025)
-$163,915.85

Guru Ownership Trend

Guru Analysis for Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics, Inc. (ALDX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.02 M.

Top institutional holders include Cliff Asness and Renaissance Technologies.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $163,915.85 net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 18.5%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$1.28 M
Total Buy Value
New Buys 1
Additions 1
-$1.44 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Aldeyra Therapeutics, Inc. (ALDX)

Major holders include Cliff Asness ($6.36 M), Renaissance Technologies ($1.81 M), Steven Cohen ($487,407). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.67 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $163,915.85, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ALDX. The total reported sell value was $1.44 M.

Yes, 1 managers opened new positions in ALDX, and 1 increased their existing holdings. The total reported buy value was $1.28 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -18.5% 1,226,922 $6.36 M Q4 2025
0.00% Add 77.4% 350,000 $1.81 M Q4 2025
0.00% New Buy 94,094 $487,407 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form